Start with the map
It usually means a place that evaluates people for medicines used in diabetes or weight care. The visit may happen in a room or by video.
There are no live listings, rankings, or matches here. This guide helps you understand the choices and check a place yourself.
First distinction
What matters is which kind of medicine is on offer, not how polished the website looks.
Approved medicine
As of September 2026, semaglutide, tirzepatide, and liraglutide appear in medicines the FDA has approved for specific uses.
Each brand is approved for certain health problems, so ask whether the brand you are offered is the one approved for your reason, such as diabetes or weight.
Compounded medicine
A compounded medicine is mixed to order by a state-licensed pharmacy, or by a larger outsourcing facility that registers with the FDA.
It has no FDA approval as of September 2026, and nobody at the agency checks it before it goes on sale.
Research-use product
A chemical sold with “research use only” wording is not a patient medicine.
Mixing water or an injection guide beside it is a reason to leave.
Choose a route
There is no single best doorway. The useful question is which route can review the whole person and stay available after the first visit.
Route A
Your regular doctor’s office may already have your medicine list, health history, and past blood test results. Start there if you want one team that knows your whole story.
Take the question list →Route B
A specialist visit can make sense when diabetes, heart disease, sleep trouble, or several medicines make the picture more involved.
Compare the medicines →Route C
Care by video or phone, called telehealth, can be real care. As of September 2026, the clinician (the doctor or other licensed professional who writes the prescription) needs a licence from whichever state you are physically in while the visit happens. Your state medical board’s website shows whether that licence is active.
Check what to avoid →Compare the visit